Principal investigator at Lomonosov University (Moscow, Russia). Dr. Metelev possess tremendous experience in the field of oligonucleotide development and has been an active collaborator and part of ZATA’s oligotherapeutics program development for over two decades. His scientific affiliation with the cofounders of ZATA started in the middle of the 90-ties. Dr. Metelev has co-published with ZATA up to a couple dozen R&D papers about the application of the novel oligonucleotides.